Of these AABs, three of them—ANGPT2, SELE, and CAV2—are detected in ARDS+ patients with a highly significant difference (Figure 4A and Figure S4) (Wilcoxon test p-value <0.05) over ARDS− patients. Here, CAV2 is linked to acute respiratory distress syndrome.